In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
